<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2024-01-24" version="94" xmlns="http://uniprot.org/uniprot">
  <accession>P10946</accession>
  <name>SPAS_BACIU</name>
  <protein>
    <recommendedName>
      <fullName>Lantibiotic subtilin</fullName>
    </recommendedName>
  </protein>
  <gene>
    <name type="primary">spaS</name>
    <name type="synonym">sub</name>
  </gene>
  <organism>
    <name type="scientific">Bacillus subtilis</name>
    <dbReference type="NCBI Taxonomy" id="1423"/>
    <lineage>
      <taxon>Bacteria</taxon>
      <taxon>Bacillota</taxon>
      <taxon>Bacilli</taxon>
      <taxon>Bacillales</taxon>
      <taxon>Bacillaceae</taxon>
      <taxon>Bacillus</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="9508" last="9514">
      <title>Structure and expression of a gene encoding the precursor of subtilin, a small protein antibiotic.</title>
      <authorList>
        <person name="Banerjee S."/>
        <person name="Hansen J.N."/>
      </authorList>
      <dbReference type="PubMed" id="2837490"/>
      <dbReference type="DOI" id="10.1016/s0021-9258(19)76571-5"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>DEHYDRATION AT SER-29; THR-42 AND SER-55</scope>
    <scope>LANTHIONINE CROSS-LINKS</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1992" name="J. Bacteriol." volume="174" first="1417" last="1422">
      <title>The subtilin gene of Bacillus subtilis ATCC 6633 is encoded in an operon that contains a homolog of the hemolysin B transport protein.</title>
      <authorList>
        <person name="Chung Y.J."/>
        <person name="Steen M.T."/>
        <person name="Hansen J.N."/>
      </authorList>
      <dbReference type="PubMed" id="1735728"/>
      <dbReference type="DOI" id="10.1128/jb.174.4.1417-1422.1992"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <source>
      <strain>ATCC 6633 / PCI 219 / NRS 231</strain>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1992" name="Appl. Environ. Microbiol." volume="58" first="132" last="142">
      <title>Analysis of genes involved in biosynthesis of the lantibiotic subtilin.</title>
      <authorList>
        <person name="Klein C."/>
        <person name="Kaletta C."/>
        <person name="Schnell N."/>
        <person name="Entian K.-D."/>
      </authorList>
      <dbReference type="PubMed" id="1539969"/>
      <dbReference type="DOI" id="10.1128/aem.58.1.132-142.1992"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <source>
      <strain>ATCC 6633 / PCI 219 / NRS 231</strain>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="1992" name="J. Bacteriol." volume="174" first="6699" last="6702">
      <title>Determination of the sequence of spaE and identification of a promoter in the subtilin (spa) operon in Bacillus subtilis.</title>
      <authorList>
        <person name="Chung Y.J."/>
        <person name="Hansen J.N."/>
      </authorList>
      <dbReference type="PubMed" id="1400221"/>
      <dbReference type="DOI" id="10.1128/jb.174.20.6699-6702.1992"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1994" name="Appl. Environ. Microbiol." volume="60" first="2793" last="2801">
      <title>Genes involved in self-protection against the lantibiotic subtilin produced by Bacillus subtilis ATCC 6633.</title>
      <authorList>
        <person name="Klein C."/>
        <person name="Entian K.-D."/>
      </authorList>
      <dbReference type="PubMed" id="8085823"/>
      <dbReference type="DOI" id="10.1128/aem.60.8.2793-2801.1994"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1973" name="Hoppe-Seyler's Z. Physiol. Chem." volume="354" first="810" last="812">
      <title>Subtilin, VI: the structure of subtilin.</title>
      <authorList>
        <person name="Gross E."/>
        <person name="Kiltz H.H."/>
        <person name="Nebelin E."/>
      </authorList>
      <dbReference type="PubMed" id="4154277"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 25-56</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1989" name="Eur. J. Biochem." volume="182" first="181" last="186">
      <title>The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes.</title>
      <authorList>
        <person name="Schueller F."/>
        <person name="Benz R."/>
        <person name="Sahl H.-G."/>
      </authorList>
      <dbReference type="PubMed" id="2471644"/>
      <dbReference type="DOI" id="10.1111/j.1432-1033.1989.tb14815.x"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MODE OF ACTION</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="1993" name="Biochem. J." volume="291" first="23" last="27">
      <title>A novel post-translational modification of the peptide antibiotic subtilin: isolation and characterization of a natural variant from Bacillus subtilis A.T.C.C. 6633.</title>
      <authorList>
        <person name="Chan W.C."/>
        <person name="Bycroft B.W."/>
        <person name="Leyland M.L."/>
        <person name="Lian L.-Y."/>
        <person name="Roberts G.C.K."/>
      </authorList>
      <dbReference type="PubMed" id="8471040"/>
      <dbReference type="DOI" id="10.1042/bj2910023"/>
    </citation>
    <scope>SUCCINYLATION AT TRP-25</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1992" name="FEBS Lett." volume="300" first="56" last="62">
      <title>Sequence-specific resonance assignment and conformational analysis of subtilin by 2D NMR.</title>
      <authorList>
        <person name="Chan W.C."/>
        <person name="Bycroft B.W."/>
        <person name="Leylands M.L."/>
        <person name="Lian L.-Y."/>
        <person name="Yang J.C."/>
        <person name="Roberts G.C.K."/>
      </authorList>
      <dbReference type="PubMed" id="1547888"/>
      <dbReference type="DOI" id="10.1016/0014-5793(92)80163-b"/>
    </citation>
    <scope>STRUCTURE BY NMR</scope>
    <scope>LANTHIONINE CROSS-LINKS</scope>
    <source>
      <strain>ATCC 6633 / PCI 219 / NRS 231</strain>
    </source>
  </reference>
  <reference key="10">
    <citation type="journal article" date="1993" name="Appl. Environ. Microbiol." volume="59" first="648" last="651">
      <title>The antimicrobial effect of a structural variant of subtilin against outgrowing Bacillus cereus T spores and vegetative cells occurs by different mechanisms.</title>
      <authorList>
        <person name="Liu W."/>
        <person name="Hansen J.N."/>
      </authorList>
      <dbReference type="PubMed" id="8434932"/>
      <dbReference type="DOI" id="10.1128/aem.59.2.648-651.1993"/>
    </citation>
    <scope>MUTAGENESIS OF SER-29</scope>
  </reference>
  <comment type="function">
    <text evidence="2">Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria. The bactericidal activity of lantibiotics is based on depolarization of energized bacterial cytoplasmic membranes, initiated by the formation of aqueous transmembrane pores.</text>
  </comment>
  <comment type="PTM">
    <text evidence="3">Maturation of lantibiotics involves the enzymatic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.</text>
  </comment>
  <comment type="PTM">
    <text evidence="6">Succinylated subtilin is 10-20 times less active than subtilin. The ratio subtilin/succinylated subtilin is about 1:2 after 24 hours growth.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">The 2,3-didehydrobutyrine is determined to be the Z-isomer.</text>
  </comment>
  <comment type="miscellaneous">
    <text>Subtilin activity is observed during stationary phase, but not during exponential growth.</text>
  </comment>
  <comment type="similarity">
    <text evidence="7">Belongs to the type A lantibiotic family.</text>
  </comment>
  <dbReference type="EMBL" id="J03767">
    <property type="protein sequence ID" value="AAA22841.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M83944">
    <property type="protein sequence ID" value="AAA22772.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M86869">
    <property type="protein sequence ID" value="AAA22840.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M99263">
    <property type="protein sequence ID" value="AAA22778.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U09819">
    <property type="protein sequence ID" value="AAB91589.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="PIR" id="A28112">
    <property type="entry name" value="NIBSSA"/>
  </dbReference>
  <dbReference type="AlphaFoldDB" id="P10946"/>
  <dbReference type="SMR" id="P10946"/>
  <dbReference type="TCDB" id="1.C.20.1.5">
    <property type="family name" value="the nisin (nisin) family"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005576">
    <property type="term" value="C:extracellular region"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="InterPro"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005102">
    <property type="term" value="F:signaling receptor binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031640">
    <property type="term" value="P:killing of cells of another organism"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR006079">
    <property type="entry name" value="Lantibiotic_typ-A_Bacillales"/>
  </dbReference>
  <dbReference type="NCBIfam" id="TIGR03731">
    <property type="entry name" value="lantibio_gallid"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02052">
    <property type="entry name" value="Gallidermin"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00324">
    <property type="entry name" value="NISIN"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0078">Bacteriocin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0425">Lantibiotic</keyword>
  <keyword id="KW-0883">Thioether bond</keyword>
  <feature type="propeptide" id="PRO_0000017142" evidence="4">
    <location>
      <begin position="1"/>
      <end position="24"/>
    </location>
  </feature>
  <feature type="peptide" id="PRO_0000017143" description="Lantibiotic subtilin">
    <location>
      <begin position="25"/>
      <end position="56"/>
    </location>
  </feature>
  <feature type="modified residue" description="N2-succinyltryptophan; partial" evidence="6">
    <location>
      <position position="25"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydroalanine (Ser)" evidence="3">
    <location>
      <position position="29"/>
    </location>
  </feature>
  <feature type="modified residue" description="(Z)-2,3-didehydrobutyrine" evidence="3">
    <location>
      <position position="42"/>
    </location>
  </feature>
  <feature type="modified residue" description="2,3-didehydroalanine (Ser)" evidence="3">
    <location>
      <position position="55"/>
    </location>
  </feature>
  <feature type="cross-link" description="Lanthionine (Ser-Cys)" evidence="1 3">
    <location>
      <begin position="27"/>
      <end position="31"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1 3">
    <location>
      <begin position="32"/>
      <end position="35"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1 3">
    <location>
      <begin position="37"/>
      <end position="43"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1 3">
    <location>
      <begin position="47"/>
      <end position="50"/>
    </location>
  </feature>
  <feature type="cross-link" description="Beta-methyllanthionine (Thr-Cys)" evidence="1 3">
    <location>
      <begin position="49"/>
      <end position="52"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Devoid of antimicrobial activity; keeps full lysis capacity." evidence="5">
    <original>S</original>
    <variation>A</variation>
    <location>
      <position position="29"/>
    </location>
  </feature>
  <evidence type="ECO:0000269" key="1">
    <source>
      <dbReference type="PubMed" id="1547888"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="2471644"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="2837490"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="4154277"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="8434932"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="8471040"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="7"/>
  <sequence length="56" mass="6218" checksum="DA9707FBF8A1EBBA" modified="1989-07-01" version="1" precursor="true">MSKFDDFDLDVVKVSKQDSKITPQWKSESLCTPGCVTGALQTCFLQTLTCNCKISK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>